Effective Use of microRNA, BRAF and Sonographic Risk Assessment in Bethesda III Thyroid Nodules Requires a Different Approach to Nodules with Features of Nuclear Atypia and Other Types of Atypia

Effective Use of microRNA, BRAF and Sonographic Risk Assessment in Bethesda III Thyroid Nodules Requires a Different Approach to Nodules with Features of Nuclear Atypia and Other Types of Atypia

The aim of the study was to analyze the diagnostic usefulness of the combined assessment of the ultrasound risk category of the nodule (evaluated with EU-TIRADS system), the presence of BRAF V600E mutation and the expression of selected microRNAs (miR-146b, miR-221 and miR-222) in Bethesda category...

Full description

Bibliographic Details
Main Authors: Dorota Słowińska-Klencka, Bożena Popowicz, Dominika Kulczycka-Wojdala, Bożena Szymańska, Joanna Duda-Szymańska, Martyna Wojtaszek-Nowicka, Krzysztof Kaczka, Mariusz Klencki
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Cancers
Subjects:
thyroid cancer
FNA
EU-TIRADS
BRAF
microRNA
AUS-nuclear
Online Access:https://www.mdpi.com/2072-6694/15/17/4287

Internet

https://www.mdpi.com/2072-6694/15/17/4287

Similar Items